Providence Health & Services

This early-stage trial is testing a personalized treatment for people with advanced cancers that cannot be cured. Doctors take a patient's own immune cells, genetically engineer them to better recognize their specific cancer, and infuse them back. These 're-trained' cells are giv…

This study is testing whether two targeted cancer drugs (encorafenib and binimetinib), given with or without an immunotherapy drug (nivolumab), can help control advanced thyroid cancer that has a specific genetic change (BRAF V600 mutation) and has stopped responding to standard …

This study is testing whether adding different immune-boosting drugs before standard chemotherapy and immunotherapy can improve treatment for triple negative breast cancer. The trial involves 12 participants with early-stage breast cancer who will receive treatment before surgery…

This trial is testing a personalized cell therapy for people with advanced cancers that have a specific genetic change called KRAS G12V. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack the cancer, and then infuse them back into the p…

This study is for people with advanced non-small cell lung cancer that has worsened after prior treatments. It aims to test the safety and find the best dose of an experimental drug called MK-3475 when given alongside a standard chemotherapy drug, gemcitabine. Researchers will mo…